Timothy Coughlin
CIK 1376043 · Chief Financial Officer · last filed 2026-06-10
Timothy Coughlin is a Chief Financial Officer who has filed 82 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for VIR, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$13.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $26.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$26.12M
8
82
-$12.99M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIR | Director | 8,000 | $8.61 | $68.9K | $0 | 1 | 2026-06-10 |
| ADCT | Director | 72,400 | $1.05 | $76.0K | $0 | 2 | 2026-06-03 |
| TVTX | Director | 56,250 | $52.04 | $2.93M | -$771.9K | 8 | 2026-05-21 |
| ATYR | Director | — | $0.44 | — | $0 | 1 | 2026-05-13 |
| LIFE | Director | 56,000 | $15.61 | $874.2K | $87.5K | 12 | 2025-05-02 |
| FATE | Director | 66,282 | $2.06 | $136.5K | $117.2K | 12 | 2024-06-11 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 32,000 | — | — | $0 | 6 | 2020-05-19 |
| NBIX | Chief Financial Officer | 137,961 | $159.76 | $22.04M | -$12.42M | 40 | 2017-02-08 |
Recent Filings
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | VIR | Grant (A) | +16,000 | $0 | EDGAR |
| 2026-06-03 | ADCT | Mixed | +32,400 | -$38.8K | EDGAR |
| 2026-05-21 | TVTX | Grant (A) | +4,000 | $0 | EDGAR |
| 2026-05-19 | TVTX | Sell (S) | −3,250 | -$141.3K | EDGAR |
| 2026-05-13 | ATYR | Grant (A) | — | $0 | EDGAR |
| 2025-11-04 | TVTX | Mixed | — | -$325.6K | EDGAR |
| 2025-06-05 | ADCT | Grant (A) | +40,000 | $0 | EDGAR |
| 2025-05-16 | TVTX | Grant (A) | +6,500 | $0 | EDGAR |
| 2025-05-02 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | FATE | Grant (A) | — | $0 | EDGAR |